Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Open-label Multicenter Parallel-group Study of Efficacy and Safety of TL-FVP-t vs. Standard of Care Therapy in Patients With Mild to Moderate Coronavirus Disease (SARS-CoV-2/COVID-19)

NCT04501783 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT04501783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04501783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Open-label Multicenter Parallel-group Study of Efficacy and Safety of TL-FVP-t vs. Standard of Care Therapy in Patients With Mild to Moderate Coronavirus Disease (SARS-CoV-2/COVID-19)
Lead sponsor
R-Pharm
Phase
Phase 3
Overall status
Completed
Start date
May 20, 2020
Completion date
August 4, 2020
Enrollment
168 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19